Balaxi Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Balaxi Pharmaceuticals has a total shareholder equity of ₹2.2B and total debt of ₹303.3M, which brings its debt-to-equity ratio to 14.1%. Its total assets and total liabilities are ₹2.9B and ₹721.0M respectively. Balaxi Pharmaceuticals's EBIT is ₹457.0M making its interest coverage ratio 24.8. It has cash and short-term investments of ₹608.7M.
Key information
14.1%
Debt to equity ratio
₹303.30m
Debt
| Interest coverage ratio | 24.8x |
| Cash | ₹608.67m |
| Equity | ₹2.16b |
| Total liabilities | ₹720.97m |
| Total assets | ₹2.88b |
Recent financial health updates
These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well
Jul 30
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet
Feb 09Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?
Aug 08Recent updates
Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues
Nov 13These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well
Jul 30Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk
May 29Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost
Feb 10Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet
Feb 09Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?
Aug 08The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested
May 20A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)
Feb 03Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)
Sep 06Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively
Jun 03Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 12Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 27
Financial Position Analysis
Short Term Liabilities: BALAXI's short term assets (₹2.4B) exceed its short term liabilities (₹693.2M).
Long Term Liabilities: BALAXI's short term assets (₹2.4B) exceed its long term liabilities (₹27.7M).
Debt to Equity History and Analysis
Debt Level: BALAXI has more cash than its total debt.
Reducing Debt: BALAXI's debt to equity ratio has increased from 0% to 14.1% over the past 5 years.
Debt Coverage: BALAXI's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: BALAXI's interest payments on its debt are well covered by EBIT (24.8x coverage).